| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |